Cadrenal Therapeutics, Inc.
CVKD
$15.50
-$0.775-4.76%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/8/2025
-
GuruFocus
5/8/2025
-
GuruFocus
5/8/2025
-
Business Wire
4/17/2025
-
GuruFocus
4/17/2025
-
Business Wire
4/3/2025
-
GuruFocus
4/3/2025
-
Business Wire
3/29/2025
-
Ticker Report
3/18/2025
-
Ticker Report
3/15/2025
-
Ticker Report
3/14/2025
-
TipRanks Financial Blog
3/13/2025
-
GuruFocus
3/13/2025
-
SeekingAlpha.com: All News
3/13/2025
-
Business Wire
3/4/2025
-
Simply Wall St
3/4/2025
-
The Fly
3/4/2025
-
Business Wire
3/4/2025
-
Simply Wall St
2/6/2025
-
GuruFocus
2/6/2025
-
The Fly
2/6/2025
-
Business Wire
2/5/2025
-
GuruFocus
2/5/2025
-
Business Wire
1/13/2025
-
BizJournals.com - Nat'l Business News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
904 300 0701
Address
822 A1A North
Ponte Vedra, FL 32082
Ponte Vedra, FL 32082
Country
Year Founded
Business Description
Sector
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel...
more